Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes.
about
Severe Thrombocytopenia after Zika Virus Infection, Guadeloupe, 2016Drug-induced thrombocytopenia in the critically ill: a case-control study.Repeated early hemofiltration filters clotting and heparin-induced thrombocytopenia in ICU.Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysisPlatelet transfusions in cancer patients with hypoproliferative thrombocytopenia in the intensive care unitThe Incidence, Clinical Outcomes, and Risk Factors of Thrombocytopenia in Intra-Abdominal Infection Patients: A Retrospective Cohort Study.Deep Vein Thrombosis in Intensive Care.Left main crossover stenting in a patient with severe thrombocytopenia due to aplastic anemia.Severe Fever with Thrombocytopenia Syndrome in South Korea, 2013-2015Natural history of nonimmune-mediated thrombocytopenia and acute kidney injury in pediatric open-heart surgery.The incidence and clinical characteristics by gender differences in patients with Kikuchi-Fujimoto diseaseDeinagkistrodon acutus envenomation: a report of three casesUnfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A cross-sectional studyAssessment of Haemostasis in Disseminated Intravascular Coagulation by Use of Point-of-Care Assays and Routine Coagulation Tests, in Critically Ill Patients; A Prospective Observational StudyRisk factors for and prediction of mortality in critically ill medical-surgical patients receiving heparin thromboprophylaxis.Platelet Counts, Acute Kidney Injury, and Mortality after Coronary Artery Bypass Grafting Surgery.A unique case of human Zika virus infection in association with severe liver injury and coagulation disorders.An introduction to multiplicity issues in clinical trials: the what, why, when and how.Stress Ulcer Prophylaxis in Neurocritical Care.Eptifibatide-Induced Profound Thrombocytopenia After Percutaneous Intervention for Acute Coronary Syndrome: A Challenging Clinical Scenario.A Case of Hyperacute Severe Thrombocytopenia Occurring Less than 24 Hours after Intravenous Tirofiban Infusion.
P2860
Q28733500-7CAA7B69-C74C-4058-85F3-E64179FDB75AQ33414170-0F55686E-1C15-4F6A-BDDE-40E7AF0379C2Q33415852-ACABE301-BBD7-4A84-A239-26433D5933E1Q33422064-1D6DB048-9AC0-4297-A676-9867E2157D1CQ33427993-4346350C-1EE9-4A2D-BB82-372022DA4937Q33429486-2F1FB08F-70CF-4BB6-B3E6-68C79F8E44B0Q33435360-992654F2-75A3-4467-85BD-AF75DD6CB0D4Q33437084-D84F683A-8635-4960-AD6D-4AC6A3E758FDQ33437970-D2DFF4EB-E407-41C2-B0A9-29EAC17D5B70Q33438533-DFA7EB83-FCA1-49A7-BC7A-7AD20CFE8E4FQ33440168-543E3CBE-614A-42E9-8C33-938609D66FC1Q33440413-949623E7-CC77-4D3F-A5D5-17007AC3BB3EQ33441234-C9A31997-CDB5-4B19-AD54-F90244C84C5DQ33442312-97F19D35-00AF-422E-8483-6E5403521759Q35951277-17F021E3-A398-4A6B-AF3D-755C69EB9E29Q36624814-8AE55B20-B97C-4623-960B-B104AF73E88FQ37292851-417FA816-A164-40D8-980C-5BDE6AA5FDDDQ40037550-074E7175-A0D9-48B6-AAB9-FB50A29D4241Q40406803-98B5A301-8E3A-4053-9933-9F57FCFF08DDQ47956386-BC1B05F1-778B-4CA5-99A1-6E87A740EDB6Q55339070-C8AD90BF-078C-4A81-B589-8DD53C9556AFQ55442994-179D31BD-6691-425A-A800-FEF262E49128
P2860
Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Thrombocytopenia in critically ...... y, risk factors, and outcomes.
@ast
Thrombocytopenia in critically ...... y, risk factors, and outcomes.
@en
type
label
Thrombocytopenia in critically ...... y, risk factors, and outcomes.
@ast
Thrombocytopenia in critically ...... y, risk factors, and outcomes.
@en
prefLabel
Thrombocytopenia in critically ...... y, risk factors, and outcomes.
@ast
Thrombocytopenia in critically ...... y, risk factors, and outcomes.
@en
P2093
P50
P356
P1433
P1476
Thrombocytopenia in critically ...... y, risk factors, and outcomes.
@en
P2093
Andreas Freitag
David R Williamson
Deborah Cook
Diane Heels-Ansdell
Donald M Arnold
Francois Lamontagne
Jamal Alhashemi
John Muscedere
Mark Crowther
P304
P356
10.1378/CHEST.13-0121
P407
P577
2013-10-01T00:00:00Z